Yokomori 3 Flashcards

1
Q

Briefly describe activation of tyosine kinase receptors.

A

1) Binding of signal molecule
2) Dimerization and autophosporylation of receptors
3) Kinase activity stimulated by cross phosphorylation between receptors
4) Phosphorylated sites act as binding sites for other proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What ligands are common for receptor tyrosine kinases and Ras? What do they mediate?

A

ligand: peptide growth hormone

Mediate cell growth and differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the general characteristics of a receptor tyrosine kinase?

A

1) extracellular and cytosol component (tyrosine kinase is on cytosol side)
2) usually has “GF” in name (ie. EGF, IGF, NGF, FGF, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Briefly describe Src tyrosine kinase.

A

1) first nonreceptor tyrosine kinase discovered
2) SH2 and SH3 domain, SH2 is the one that recognizes phosphorylated tyrosine (know this about SH2)
3) mutation associated with cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Briefly describe Ras

A

Small GTPases regulate many aspects of grwoth, differentiation, and migration in response to extracellular signals.

Super family contains Rho/Rac, Rab, and Ran.

  • Signals transmitted from tyrosine kinases to serine/threonine kinases which then go to cell nucleus.
  • Ras mutation involved in 20-30% of cancers, big oncogene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Briefly describe receptor tyrosine kinase and Ras activation.

A

1) Binding of ligand cause dimerzation and autophosporylation of tyrosine residues
2) Causes binding of GRB2 to phosorylated tyrosine. Sos binds to GRB2 which binds to the inactive Ras (inactive bound to Ras)
3) GTP binds to Ras and becomes active, causing it to dissociate from Sos (like G-alpha)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Briefly describe Ras GTPase activity.

A

1) Inactive Ras bound to GDP
2) Guanine nucleotide exchange factors (GEF; also called Sos) causes releases of GDP
3) High concentration of GTP results in GTP binding and activated Ras
4) GTPase activated proteins (GAP) stimulates GTPase activity of Ras causing GTP -> GDP hydroylysis; resulting in deactivation of the GTPase

Ras GTPase is normally SLOW. needs GAP for efficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the downstream target of Ras?

A

Ras -> MAP kinase kinase kinase (Raf) -> MAP kinase kinase (Mek) -> Map kinase (Erk); this goes on to activate pathways such as protein activity and gene expression.

Ras activates MAP kinase serine/threonin phosphorylation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does MAPK regulate transcription in nucleus?

A

1) RTK activates Ras
2) Ras activates MAPK
3) MAPK enters nucleus and phosphorylates TCF and SRF (serum response factor)
4) This activates SRE (serum response element); results in gene transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What class of syndromes result from Ras pathway mutation?

A

Neuro-cardio-facial-cutaneous (NCFC) syndromes

-Ras pathway is important for cognition, growth, and development

Remember Ras also involved in oncogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In addition to Ras, RTKs also activate?

A

RTKs -> Ras -> MapK

alternatively: RTKs + Ras -> PI3k

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does PI 3-kinase do?

A

Phosphorylates inositol phospholipids (phosphorylates lipids) which can then signal other pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe how PI 3-kinase promotes cell survival. What regulates this pathway?

A

1) PI 3-kinase activated by RTK or Ras-GTP
2) Phophorylates inositol phospholipid (PI)
3) PKB binds to PI and becomes activated
4) This phosphorylated PKB now activates an apoptosis inibitory protein RESULTING in inhibition of apoptosis
- Regulated by PTEN which is antagonist (inhibitor) of PI 3-kinase, removes phosphates from PI; terminates signal by PI 3-kinase. PTEN is phosphatase. No PTEN means no apoptosis -> cancer (tumor suppressor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do insulin receptors work?

A

1) Insulin receptor is dimer, binding of insulin activates the RTK
2) IRS-tyr is phosphorylated (insulin receptor substrates)
3) Phosphorylated IRS-tyr goes on to carry on activity of insulin (activation of PKB, glucose uptake, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the JAK STAT pathway important for?

A

-Cytokine signaling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are cytokines?

A

important in cell to cell communication; includes:

  • interluekins (ILs)
  • interferons (IFNs)
  • colony stimulating factors (CSFs)
  • required for immunity, hematopoiesis, and inflammation as well as neural and embryonic development (infection and development pretty much)
17
Q

Describe activation of JAK-STAT pathway

A

1) cytokine binds, causing JAK on two different receptors to cross phosphorylate each other (receptors dimerize)
2) Activate JAKs phosphorylate receptors on tyrosines
3) STATs bind to tyr, the STATS are phosphorylated by JAK
4) STATs dissociate and dimerize
5) STATs dimer enters nucleus and act as transcription factor to activate gene transcription

18
Q

What is the fxn of STAT1? What happens during deficiency of it?

A

-activates macrophages (immune system) in response to IFN (interferon). Deficiency results in extremem sensitivity to viral and microbial infections in mice.

19
Q

What can happen as a result of hyperactive JAK proteins? What is the role of erythropoietin?

A

Hematopoietic malignancies (ie. leukemia)

-ertythropoietin (EPO) is a hormone (made in kindey) that stimulates a cell to become a RBC. If a hematopoietic stem cell which has EPO receptors does not detect EPO, it undergoes apoptosis. With EPO, it becomes a RBC.

20
Q

Ertyhropoietin receptor (EcoR) and JAK2 are essential for develop of what cells?

A

Erythrocytes, no EpoR or JAK2 = anemia

21
Q

Besides STAT, what else does JAK stimulate?

A

GRB2 or SHC (MAPK pathway), phospholipase C (Ca2+ release pathway), and PI-3 kinase (PKB pathway)

22
Q

What is the importance of TGF-B/Smad pathway?

A

Important in cell differentiation; developmental processes

serine/threonine kinase activity

-TGF = transforming growth factor

23
Q

Briefly describe TGFB-SMAD signal transduction.

A

Type I and type II receptors (2 each)

1) Type II phosphorylates type I at serine/threonine residues. Results in activation of type I receptors
2) Type I then phosphorylates SMAD protein
3) SMAD proteins oligomerize and enter nucleus where they interact with other transcription factors to active transcription

24
Q

SMAD mutations common results in?

A

Human cancers; especially pancreatic cancer

in mice: SMAD3 knockout = metastatic colorectal adenocarcinoma

25
Q

What is TGF-B’s impact in cancer?

A

Tumor promoter and pro-metastatic factor

26
Q

JAK/STAT vs TGFB/SMAD

A

J/S: important for development and immune response (involved with erythropoietin)

T/S: important for differentiation and development (involved in cancer)

27
Q

What is the WNT pathway?

A
  • wingless and INT-1 signaling pathway
  • Important for stem cell maintainence and differentiation (important for embryonic development)
  • mutation = cancer
28
Q

What stem cells do adults have that are affected by WNT signaling?

A

1) intestinal epithelial (intestine)
2) hematopoietic (RBC)
3) hair follical (hair)
4) mesenchymal (bone)

29
Q

Describe WNT pathway

A

No WNT

1) Beta-catenin levels kept low by degradation
2) Complex involving APC is responsible for keeping B-catenin levels low

With WNT

1) Beta-catenin is allowed to enter the nucleus and activate transcription of WNT target genes

30
Q

What is familial adenomatous polyposis (FAP)?

A
  • FAP is autosomal, dominant disease
  • susceptible to colorectal cancer (intestinal cancer)
  • caused by APC mutation, which results in accumulation of beta-catenin
  • excess B-cantenin activates cell proliferation; resulting in formation of adenomatous polyps (lesions)